Mel-Mont Medical

Doral, United States Founded: 2014 • Age: 12 yrs
Molecular screening devices for early infectious disease detection are developed.
Request Access

About Mel-Mont Medical

Mel-Mont Medical is a company based in Doral (United States) founded in 2014 by Liliana Montes and Frank Melendez.. Mel-Mont Medical has raised $10.15 million across 3 funding rounds. Mel-Mont Medical operates in a competitive market with competitors including OpGen, Day Zero Diagnostics, Clear Labs, Karius and Seegene Technologies, among others.

  • Headquarter Doral, United States
  • Founders Liliana Montes, Frank Melendez
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $10.15 M (USD)

    in 3 rounds

  • Latest Funding Round
    $250 K (USD), Series A

    Dec 11, 2025

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Mel-Mont Medical

Mel-Mont Medical has successfully raised a total of $10.15M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $250 thousand completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series A — $250,000
  • First Round

    (20 Nov 2020)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2025 Amount Series A - Mel-Mont Medical Valuation

investors

Aug, 2023 Amount Series A - Mel-Mont Medical Valuation

investors

Nov, 2020 Amount Seed - Mel-Mont Medical Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Mel-Mont Medical

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Mel-Mont Medical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Mel-Mont Medical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Mel-Mont Medical

Mel-Mont Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, Day Zero Diagnostics, Clear Labs, Karius and Seegene Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of diagnostics and bioinformatics platforms for providers
domain founded_year HQ Location
Genome sequencing diagnostics for infectious diseases are developed.
domain founded_year HQ Location
Food safety technologies are provided for pathogen identification.
domain founded_year HQ Location
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
domain founded_year HQ Location
Developer of molecular diagnostic kits to detect infectious and genetic diseases
domain founded_year HQ Location
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Mel-Mont Medical

Frequently Asked Questions about Mel-Mont Medical

When was Mel-Mont Medical founded?

Mel-Mont Medical was founded in 2014 and raised its 1st funding round 6 years after it was founded.

Where is Mel-Mont Medical located?

Mel-Mont Medical is headquartered in Doral, United States. It is registered at Doral, Florida, United States.

Who is the current CEO of Mel-Mont Medical?

Frank Melendez is the current CEO of Mel-Mont Medical. They have also founded this company.

Is Mel-Mont Medical a funded company?

Mel-Mont Medical is a funded company, having raised a total of $10.15M across 3 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on Nov 20, 2020.

What does Mel-Mont Medical do?

Developer of molecular screening devices for the early detection of infectious diseases. The company develops a diversified portfolio of proprietary technologies and medical devices for the early identification of DNA and RNA virus-related pathologies. The product portfolio includes XytoTest and Anal test for cervical cancer, and HR-HPV DNA detection. Also, offers in-vitro diagnostic tests for the detection of HPV infections.

Who are the top competitors of Mel-Mont Medical?

Mel-Mont Medical's top competitors include Clear Labs, Day Zero Diagnostics and Karius.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available